A Randomized, Multicenter, Open-Label, Phase II Study Of VELCADE Alone Or VELCADE Plus Docetaxel In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
Phase of Trial: Phase II
Latest Information Update: 08 Feb 2008
At a glance
- Drugs Bortezomib; Docetaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 08 Feb 2008 Status change from In progress to completed.
- 04 Sep 2005 New trial record.